Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials. [electronic resource]
Producer: 20190806Description: 863-871 p. digitalISSN:- 1572-0241
- Adult
- Black or African American -- statistics & numerical data
- Aged
- Aged, 80 and over
- Antiviral Agents -- therapeutic use
- Benzofurans -- therapeutic use
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Drug Combinations
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- therapeutic use
- Male
- Middle Aged
- Quinoxalines -- therapeutic use
- RNA, Viral -- isolation & purification
- Retrospective Studies
- Ribavirin -- therapeutic use
- Sustained Virologic Response
- Treatment Failure
- Young Adult
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.